AN2 Therapeutics, Inc. Common Stock
Symbol: ANTX (NASDAQ)
1.30
▲ (1.56%) 0.020
Company Description:
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.
Key Stats
- Today's Open: $1.27
- Today's High: $1.36
- Today's Low: $1.27
- Today's Volume: 129.22K
- Yesterday Close: $1.28
- Yesterday High: $1.3
- Yesterday Low: $1.27
- Yesterday Volume: 23.38K
- Last Min Volume: 1
- Last Min High: $1.3
- Last Min Low: $1.3
- Last Min VWAP: $1.3
Company Profile
- Name: AN2 Therapeutics, Inc. Common Stock
- Website: https://www.an2therapeutics.com
- Listed Date: 2022-03-25
- Location: MENLO PARK, CA
- Market Status: Active
- CIK Number: 0001880438
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $35.52M
- Round Lot: 100
- Outstanding Shares: 27.33M
- Asset Type: CS
RECENT FILINGS FOR ANTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-07-11 | 4 | View |
| 2025-07-11 | 4 | View |
| 2025-07-11 | 4 | View |
| 2025-06-20 | 8-K | View |
| 2025-06-18 | SCHEDULE 13D/A | View |
| 2025-06-16 | 4 | View |
| 2025-06-11 | 8-K | View |
| 2025-06-04 | SCHEDULE 13G | View |
| 2025-06-03 | 4 | View |
| 2025-05-30 | SCHEDULE 13D/A | View |
| 2025-05-30 | 4 | View |
| 2025-05-29 | 4 | View |
| 2025-05-27 | 8-K | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
Latest News on ANTX